The market for treating vaginal and vulval inflammatory illnesses is set to experience significant growth in the coming years. According to recent projections, the market is expected to reach a value of USD 2.96 billion in fiscal year 2023, up from USD 2.8 billion in the previous year. This upward trend is projected to continue, with a steady 5.8% CAGR anticipated between 2023 and 2033, ultimately reaching a value of USD 5.21 billion by the end of the forecast period.
Key Factors Driving Market Growth:
- Rising Prevalence: A significant proportion of women experience vaginal and vulval inflammation at least once in their lifetime.
- Diverse Symptoms: The condition presents with a range of symptoms, including swelling, burning, itching, and abnormal discharge.
- Complex Treatment Needs: Treatment regimens vary depending on the severity of the infection and individual patient factors.
Market Outlook:
The increasing prevalence of vaginal and vulval inflammation, coupled with the growing demand for effective treatments, is driving the growth of this market. As the healthcare industry continues to evolve, innovative therapies and advanced diagnostic tools are expected to further fuel market expansion.
Key Takeaways from the Market Study:
- The market for vaginal and vulval inflammatory diseases expanded at a CAGR of 5.2% from 2018 to 2022.
- The market for vaginal and vulval inflammatory diseases is expected to grow steadily from 2023 to 2033, at a 5.8% CAGR.
- It is projected that vaginal burning by indication type will dominate in 2023 with a 53% revenue share.
- With a 25% market share in 2023, the specialty clinic sector by end-user will hold the second-largest segment throughout the projected period.
- From 2023 to 2033, the North American region is expected to expand at a constant CAGR of 6.4%.
- From 2023 to 2033, the Asia Pacific vaginal and vulval inflammatory diseases treatment market is anticipated to expand at a stable CAGR of 5.8%.
“The changing lifestyle among the women, optic for smoking and drinking, increasing incidences of diabetes and increasing research in this domain are the primary drivers of this market.” comments a Future Market Insights analyst.
Heightened Market Interest: Our Complete Report Delivers Extensive Analysis and Trends!
Competitive Landscape:
- Almirall
- VenusConcept
- ThermiGen LLC
- Lutronic
- BTL Group of Companies
- Viveve
- Fotona
- Evofem Biosciences, Inc.
- Spero Therapeutics
- Hologic
- Kyung Hee University Hospital
Key Market Developments by Leading Players:
- Evofem Biosciences, Inc.
In May 2022, Evofem Biosciences, Inc. shared additional findings from the Phase 3 EMPOWER clinical study of Phexxi® (a combination of lactic acid, citric acid, and potassium bitartrate). The results highlighted that women participating in the EMPOWER trial experienced fewer urinary tract infections (UTIs) compared to the general population. Evofem is committed to advancing women’s reproductive and sexual health by developing and commercializing innovative, hormone-free, woman-controlled solutions, including contraception and protection against gonorrhea and chlamydia. Phexxi®, the company’s first FDA-approved product, is a prescription-only, hormone-free vaginal gel contraception.
- Spero Therapeutics
In January 2022, the US Food and Drug Administration (USFDA) granted Priority Review for Spero Therapeutics’ tebipenem HBr (tebipenem pivoxil hydrobromide) New Drug Application. This antibiotic is designed for the treatment of patients with complicated urinary tract infections (cUTI), including pyelonephritis, caused by susceptible bacteria.
Key Segments Covered In The Vaginal And Vulval Inflammatory Diseases Treatment Market Report
Vaginal And Vulval Inflammatory Diseases Treatment Market By Indication:
- Vaginal Dryness
- Vaginal Burning
- Vaginal Discharge
- Genital Itching
- Recurrent Urinary Tract Infections
- Urinary Incontinence
- Others
Vaginal And Vulval Inflammatory Diseases Treatment Market By Treatment:
- Anti-Itch Medications
- Corticosteroid Ointments
- Anti-Itch Emollients
Vaginal And Vulval Inflammatory Diseases Treatment Market By End User:
- Hospital Pharmacies
- Specialty Clinics
- Others
Vaginal and Vulval Inflammatory Diseases Treatment Market By Region:
- North America
- Latin America
- Asia Pacific
- Europe
- Middle East & Africa (MEA)
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:
Stool Management Systems Industry
Oscillating Positive Expiratory Pressure (OPEP) Devices Industry
Robotic Catheterization Systems Industry
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube